Gary has over 15 years of drug discovery and translational research experience at both strategic and operational levels. Before joining RayzeBio, he was SVP, Translational Medicine at QED Therapeutics, leading all aspects of translational research and companion diagnostics. Prior to QED, he was VP of Translational Research at Ignyta, where he built a highly productive research team from ground up and led multiple programs to NDA and IND milestones. Before Ignyta, he held various scientific positions with increasing responsibilities at Pfizer and Johnson & Johnson, contributing to target ID/validation, drug discovery and multiple drug approvals.
Gary earned his Ph.D. in Biomedical Sciences from the University of Pennsylvania School of Medicine. He is an inventor of multiple patents, and has published more than 50 peer-reviewed articles and delivered over 70 invited talks and meeting presentations.